ADVERTISEMENTs
Velocity, Palantir join hands to streamline clinical-trials payment systems using AI
Velocity CTO Raghu Punnamraju talked about the partnership's ability to save time and make the payments process error-free.
-
Staff Reporter - Fri, 18, Jul 2025
- 01:55 EDT
- 10
Velocity CTO Raghu Punnamraju / Velocity Clinical Research
Velocity Clinical Research, a North Carolina based company that does integrated site organization for clinical trials, is partnering with Palantir Technologies, a Colorado based company that specializes in software platforms.
Seeking to automate and streamline the payments reconciliation process in clinical trials, this collaboration marks a milestone in applying advanced artificial intelligence (AI) to one of the industry’s most persistent administrative challenges.
Reconciling invoices and payments in clinical research has long been a fragmented, time-consuming, and error-prone task. However, with this collaboration, advanced artificial intelligence (AI) tools would be used to streamline the task.
ALSO READ: Dr Sneha Mantri appointed first-ever CMO at Parkinson’s Foundation
The partnership between Velocity and Palantir represents a significant step toward modernizing clinical trial operations and unlocking efficiencies that will benefit sponsors, sites, and, most importantly, patients.
Raghu Punnamraju, Chief Technology Officer at Velocity, said “Velocity’s partnership with Palantir is one more example of how our size and scale is bringing new types of partnerships and innovation to the clinical trials sector. Automating the AR reconciliation process is a game-changer for clinical trial sites."
He added, "our collaboration turns months of manual effort into near-instantaneous insights, enabling our finance teams to focus on strategic, high-value work instead of wrestling with spreadsheets. ”
Payments, frequently tied to patient visits or performance-based milestones, vary significantly across studies and sites. This variability makes forecasting revenue, managing cash flow, and aligning payments with budgets extremely challenging for finance teams.
Velocity’s journey to address this issue began last year when its technology team piloted generative AI (Gen AI) agents to identify missed revenue opportunities, such as unrecorded monitoring visits. This initiative laid the foundation for a broader automation project. When Palantir approached Velocity to explore life sciences use cases for its advanced AI technology, automating accounts receivable (AR) reconciliation quickly emerged as a natural fit. Velocity brought deep clinical operations expertise, while Palantir contributed its industry-leading AI systems and modeling capabilities.
With financial workflows now automated through this partnership, Velocity is exploring opportunities to expand intelligent automation into other operational areas.
Related
.jpg)
.jpg)
.JPG)
.jpg)
.jpg)
.jpg)
.jpg)
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login